These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20540016)

  • 1. [Anticoagulant therapy in patients with atrial fibrillation on dialysis: between the risk of hemorrhage and vascular calcification].
    Cozzolino M; Ronga C; Cusi D
    G Ital Nefrol; 2010; 27(3):237-9. PubMed ID: 20540016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of atrial fibrillation in dialyzed patients: the role of oral anticoagulants. The nephrologist's point of view].
    Scanziani R; Galassi A
    G Ital Nefrol; 2010; 27(3):230-6. PubMed ID: 20540015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of atrial fibrillation in dialyzed patients: the role of oral anticoagulants. The cardiologist's point of view].
    Lucreziotti S; Lombardi F
    G Ital Nefrol; 2010; 27(3):222-9. PubMed ID: 20540014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Warfarin in haemodialysis patients with atrial fibrillation: what benefit?
    Yang F; Chou D; Schweitzer P; Hanon S
    Europace; 2010 Dec; 12(12):1666-72. PubMed ID: 21045011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of thromboembolism in non-rheumatic atrial fibrillation: an update].
    Pengo V; De Caterina R
    Ital Heart J Suppl; 2001 Sep; 2(9):972-9. PubMed ID: 11675834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 7. [Embolic complications of chronic atrial fibrillation].
    Koenig A; Théolade R; Chauvin M; Brechenmacher C
    Arch Mal Coeur Vaiss; 1992 Mar; 85(3):315-23. PubMed ID: 1575609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic renal disease and stroke in atrial fibrillation: balancing the prevention of thromboembolism and bleeding risk.
    Lip GY
    Europace; 2011 Feb; 13(2):145-8. PubMed ID: 21138929
    [No Abstract]   [Full Text] [Related]  

  • 9. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    DiMarco JP; Flaker G; Waldo AL; Corley SD; Greene HL; Safford RE; Rosenfeld LE; Mitrani G; Nemeth M;
    Am Heart J; 2005 Apr; 149(4):650-6. PubMed ID: 15990748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
    Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
    Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [SFAAT: the study of nonrheumatic chronic atrial fibrillation in the Trieste area. Results of an enrollment study].
    Scardi S; Mazzone C; Goldstein D; Pandullo C; Poletti A; Humar F; Pivotti F; De Santis C
    G Ital Cardiol; 1995 Feb; 25(2):173-82. PubMed ID: 7642022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anticoagulant treatment of patients with atrial fibrillations: dependent on age and other risk factors for thromboembolism].
    Vink R; van den Brink RB; Levi M
    Ned Tijdschr Geneeskd; 2002 Nov; 146(48):2285-9. PubMed ID: 12497755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.
    Ruiz-Nodar JM; Marín F; Hurtado JA; Valencia J; Pinar E; Pineda J; Gimeno JR; Sogorb F; Valdés M; Lip GY
    J Am Coll Cardiol; 2008 Feb; 51(8):818-25. PubMed ID: 18294566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of thromboembolic complications in patients with atrial fibrillation.
    Spiezia L; Prandoni P
    Minerva Cardioangiol; 2008 Dec; 56(6):643-52. PubMed ID: 19092739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of combined anticoagulant (fluindione)-aspirin therapy in patients with atrial fibrillation at high risk for thromboembolic complications. A randomized trial (FFAACS)].
    Lechat P; Lardoux H; Mallet A; Sanchez P; Derumeaux G; Lecompte T; Maillard L; Mas JL; Mentré F; Pousset F; Lacomblez L; Pisica G; Solbes-Latourette S; Raynaud P; Chaumet-Riffaud P;
    Therapie; 2000; 55(6):681-9. PubMed ID: 11234463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ought dialysis patients with atrial fibrillation be treated with oral anticoagulants?
    Vázquez E; Sánchez-Perales C; García-Cortes MJ; Borrego F; Lozano C; Guzmán M; Gil JM; Liébana A; Pérez P; Borrego MJ; Pérez V
    Int J Cardiol; 2003 Feb; 87(2-3):135-9; discussion 139-41. PubMed ID: 12559531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
    Mant JW
    Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of thromboembolic events in atrial fibrillation.
    Koefoed BG; Gulløv AL; Petersen P
    Thromb Haemost; 1997 Jul; 78(1):377-81. PubMed ID: 9198182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antithrombotic therapy in atrial arrhythmia].
    Cohen A
    Rev Prat; 2004 Feb; 54(3):298-307. PubMed ID: 15134239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oral anticoagulation for prevention of thromboembolism in non-rheumatic atrial fibrillation: indications, effectiveness and risk].
    Kottkamp H; Willems S; Hindricks G; Chen X; Haverkamp W; Hasfeld M; Borggrefe M; Breithardt G
    Z Kardiol; 1993 Nov; 82(11):667-73. PubMed ID: 8291287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.